Position in EOLS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$282,463
-$183,362 QoQ
Shares Held
68,726
-1.9% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. EOLS ranks #38 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in EOLS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $282,463 | 68,726 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $465,825 | 70,049 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $507,937 | 82,726 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $783,706 | 85,093 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,003,735 | 83,436 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $884,844 | 80,149 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,269,869 | 78,387 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $883,613 | 81,439 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $895,958 | 63,997 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $728,107 | 69,146 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $583,461 | 63,836 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $459,289 | 63,176 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $470,545 | 55,620 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $408,844 | 54,440 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $421,731 | 52,389 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $552,774 | 47,653 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $384,363 | 34,257 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $199,557 | 30,654 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $231,251 | 30,348 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $366,230 | 28,951 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $316,683 | 24,379 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $84,299 | 25,089 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $84,733 | 21,671 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $137,328 | 25,911 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $72,927 | 17,573 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||